Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference211 articles.
1. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors;Meric-Bernstam;Clin Cancer Res,2012
2. The phosphatidylinositol 3-kinase-AKT pathway in human cancer;Vivanco;Nat Rev Cancer,2002
3. Defining the role of mTOR in cancer;Guertin;Cancer Cell,2007
4. mTOR signaling in growth control and disease;Laplante;Cell,2012
5. A new mutational aktivation in the PI3K pathway;Brugge;Cancer Cell,2007
Cited by 167 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging targets in amyotrophic lateral sclerosis (ALS): The promise of ATP-binding cassette (ABC) transporter modulation;Behavioural Brain Research;2025-01
2. Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis;Cell Biology International;2024-08-20
3. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17
4. Heme oxygenase 1 (HO1) regulates autophagy and apoptosis via the PI3K/AKT/mTOR signaling pathway of yak Sertoli cells;Theriogenology;2024-05
5. Determination of the Protective Impact of Hypericum perforatum Extract Against Ovarian Ischemia and Reperfusion in Rats;Crescent Journal of Medical and Biological Sciences;2024-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3